Board of Directors

Officers

John G. Dent, Ph.D., Chair
GlaxoSmithKline Consumer Healthcare, Retired

Charles E. Hamner, Jr., D.V.M., Ph.D., Vice Chair
Chairman and CEO
Hamner Advisory Services, Inc.

William F. Greenlee, Ph.D., President and Chief Executive Officer
The Hamner Institutes for Health Sciences

Robert W. Rickard, Ph.D., Treasurer
DuPont Distinguished Scientist
DuPont SHE and Sustainable Growth Center

Joseph S. Pagano, M.D., Secretary
Director Emeritus, Lineberger Comprehensive Cancer Center
Lineberger Professor of Cancer Research
The University of North Carolina at Chapel Hill

Jamie H. Wilkerson, CPA, CGMA, Assistant Treasurer (non-Board member)
The Hamner Institutes for Health Sciences

Edna A. Mangum, A.A., Assistant Secretary (non-Board member)
The Hamner Institutes for Health Sciences

 

Other Board Members

Edward W. Carney, Ph.D.
Scientific Director, Toxicology Research
The Dow Chemical Company

Robert C. Eubanks
Founder and Chairman, Franklin Street Partners

Garheng Kong, M.D., Ph.D., M.B.A.
Managing General Partner
Sofinnova Ventures

Joel S. Marcus, J.D., C.P.A.
Chief Executive Officer and
Chairman of the Board of Directors
Alexandria Real Estate Equities, Inc.

 

The Hamner Institutes General Counsel

William G. Pappas, Esq.
Parker, Poe, Adams & Bernstein, L.L.P.